155 related articles for article (PubMed ID: 8986952)
1. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.
Jackson P; Petrik J; Alexander GJ; Pearson G; Allain JP
J Med Virol; 1997 Jan; 51(1):67-79. PubMed ID: 8986952
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
3. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.
Bassett SE; Thomas DL; Brasky KM; Lanford RE
J Virol; 1999 Feb; 73(2):1118-26. PubMed ID: 9882313
[TBL] [Abstract][Full Text] [Related]
4. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
5. Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library.
Chan SW; Bye JM; Jackson P; Allain JP
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2531-9. PubMed ID: 8887487
[TBL] [Abstract][Full Text] [Related]
6. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
[TBL] [Abstract][Full Text] [Related]
7. Sequence evolution and cross-reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection.
Hjalmarsson S; Blomberg J; Grillner L; Pipkorn R; Allander T
J Med Virol; 2001 Jun; 64(2):117-24. PubMed ID: 11360243
[TBL] [Abstract][Full Text] [Related]
8. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.
Shang D; Zhai W; Allain JP
Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577
[TBL] [Abstract][Full Text] [Related]
9. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
[TBL] [Abstract][Full Text] [Related]
10. Immune Reactivity of Synthetic Peptides Originated from Hypervariable Region 1 of Hepatitis C Synthetic Consensuses with Egyptian Sera Infected with Hepatitis C Virus Type 4.
Abdel-Fattah M; Charmy R; Tawfik AR
Intervirology; 2015; 58(4):232-41. PubMed ID: 26330263
[TBL] [Abstract][Full Text] [Related]
11. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
Sällberg M; Rudén U; Wahren B; Magnius LO
Clin Exp Immunol; 1993 Mar; 91(3):489-94. PubMed ID: 7680297
[TBL] [Abstract][Full Text] [Related]
12. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia.
Gabrielli A; Zhang ZX; Cherubini G; Candela M; Savoldi S; Manzin A; Clementi M; Amoroso A; Sallberg M
Clin Exp Immunol; 1996 Jul; 105(1):59-64. PubMed ID: 8697636
[TBL] [Abstract][Full Text] [Related]
13. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.
Ray R; Khanna A; Lagging LM; Meyer K; Choo QL; Ralston R; Houghton M; Becherer PR
J Virol; 1994 Jul; 68(7):4420-6. PubMed ID: 8207814
[TBL] [Abstract][Full Text] [Related]
14. Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system.
Buratti E; Di Michele M; Song P; Monti-Bragadin C; Scodeller EA; Baralle FE; Tisminetzky SG
Clin Diagn Lab Immunol; 1997 Mar; 4(2):117-21. PubMed ID: 9067642
[TBL] [Abstract][Full Text] [Related]
15. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
[TBL] [Abstract][Full Text] [Related]
16. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.
Weiner AJ; Geysen HM; Christopherson C; Hall JE; Mason TJ; Saracco G; Bonino F; Crawford K; Marion CD; Crawford KA
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3468-72. PubMed ID: 1314389
[TBL] [Abstract][Full Text] [Related]
17. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
[TBL] [Abstract][Full Text] [Related]
19. High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice.
Hitomi Y; McDonnell WM; Baker JR; Askari FK
Viral Immunol; 1995; 8(2):109-19. PubMed ID: 8825296
[TBL] [Abstract][Full Text] [Related]
20. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
